Marrett L D, Meigs J W, Flannery J T
Am J Epidemiol. 1982 Jul;116(1):57-67. doi: 10.1093/oxfordjournals.aje.a113402.
The incidence of cancer of the uterine corpus diagnosed in the localized 1964 and 1969. During the next six years, however, it increased substantially, reaching a peak in 1975, followed by an irregular decline through 1979. Women aged 45-64 years showed both the largest increase and the sharpest decline. The incidence of tumors diagnosed with regional or distant spread has been rising slightly but consistently through the period 1970-1979; this upward trend is statistically significant (p less than 0.01). Rates corrected for hysterectomized women not truly at risk are 40-50% higher than uncorrected rates but trends are the same. Explanations which are considered are changes in diagnostic practices and changes in risk factor prevalence. The use of noncontraceptive oral estrogens, a well documented risk factor for endometrial cancer, increased between 1964 and 1975 and then declined sharply through 1979 in the United States. The importance of these compounds in explaining the observed incidence trends is considered in terms of the major time- and stage-specific features of the exogenous estrogen-endometrial cancer association reported in the case-control studies.
1964年至1969年期间诊断出的子宫体癌发病率处于局部阶段。然而,在接下来的六年中,其发病率大幅上升,于1975年达到峰值,随后在1979年之前呈不规则下降趋势。45至64岁的女性发病率上升幅度最大且下降幅度也最明显。1970年至1979年期间,诊断为区域或远处扩散的肿瘤发病率一直呈轻微但持续的上升趋势;这种上升趋势具有统计学意义(p小于0.01)。对未真正处于风险中的子宫切除女性进行校正后的发病率比未校正的发病率高40%至50%,但趋势相同。所考虑的解释包括诊断方法的变化和风险因素流行率的变化。在美国,作为子宫内膜癌一个有充分记录的风险因素,非避孕口服雌激素的使用在1964年至1975年间增加,然后在1979年之前急剧下降。根据病例对照研究报告的外源性雌激素与子宫内膜癌关联的主要时间和阶段特异性特征,考虑了这些化合物在解释观察到的发病率趋势方面的重要性。